News Quantified

AUTL – autolus therapeutics plc - american depositary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Autolus Therapeutics (NASDAQ:AUTL) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.

Autolus Therapeutics (NASDAQ:AUTL) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Autolus Therapeutics (AUTL) Valuation Check After Revenue Guidance And AUCATZYL UK And EU Approvals [Yahoo! Finance]

Autolus Therapeutics (NASDAQ:AUTL) had its price target lowered by analysts at Needham & Company LLC from $11.00 to $10.00. They now have a "buy" rating on the stock.

-2.9%

MISS

-0.4%

BEAT

2.3%

MISS

Needham & Company LLC

Form 424B3 Autolus Therapeutics

Form 8-K Autolus Therapeutics For: Jan 21

Form 424B3 Autolus Therapeutics

Form 8-K Autolus Therapeutics For: Jan 12

Form SCHEDULE 13G/A Autolus Therapeutics Filed by: MAK Capital Fund LP

Top News Gainers

3/25 Visiongain Report Looks at Opportunities Within the $23bn Cell Therapy Technologies Market 18.8%

3/3 Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Progress 6.7%

5/14 Q1/2019 3/31/2019 EPS -0.690 ZacksConsensus -0.580 ActVsEst (0.110) - Miss 6.5%

12/7 Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers 6.4%

11/5 Autolus Therapeutics to Present Preclinical Data on AUT06NG at the SITC Annual Meeting 6.0%

4/14 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Global Market Insights and Forecast to 2030 - ResearchAndMarkets.com 5.7%

3/19 Autolus Therapeutics (AUTL) Investor Presentation - Slideshow [Seeking Alpha] 5.4%

2/13 The Alliance for Regenerative Medicine Releases Agenda for 2020 Cell & Gene Meeting on the Mediterranean 4.9%

4/21 Autolus Therapeutics Ltd - (NASDAQ: AUTL) is now covered by analysts at Mizuho. They set a "buy" rating on the stock. 4.7%

10/9 3 Companies To Watch For At November’s Society for Immunotherapy of Cancer Meeting [The Motley Fool] 4.6%

Top News Decliners

1/22 Autolus Announces Proposed Public Offering in the United States -14.6%

8/9 Autolus Therapeutics plc (AUTL) CEO Christian Itin on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -13.6%

8/8 Form 6-K Autolus Therapeutics For: Jun 30 -13.0%

8/8 Q2/2019 6/30/2019 EPS -0.650 ZacksConsensus -0.760 ActVsEst 0.110 - Beat -12.1%

3/9 Maryland Tech Council Announces the Finalists for the Industry Awards Celebration -11.0%

5/7 Autolus Therapeutics to Report First Quarter 2019 Financial Results and Host Conference Call on May 14 -8.1%

2/25 Autolus Therapeutics to Present at the Cowen 40th Annual Health Care Conference -8.1%

9/9 Form SC 13G/A Autolus Therapeutics Filed by: Woodford Patient Capital Trust Plc -7.8%

2/18 Cell Therapy Manufacturing Market Landscape & Opportunity Assessment, 2019-2030 -7.2%

11/12 Autolus Therapeutics Ltd - (NASDAQ: AUTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. -6.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day